Home > Insider Trading > Filing (0001209191-23-057239)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061027	Viracta Therapeutics Inc.	VIRX	Pharmaceutical Preparations (2834)	943295878

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550424	Mark Rothera	C/O Viracta Therapeutics, Inc. 2533 S Coast Hwy 101, Suite 210 Cardiff CA 92007	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-11-30	52,094	$0.49	52,094	No	4	P	Direct
Common Stock	Acquisiton	2023-12-01	47,906	$0.49	100,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Represents the weighted average share price of an aggregate total of 52,094 shares purchased in the price range of $0.48 to $0.51 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Represents the weighted average share price of an aggregate total of 47,906 shares purchased in the price range of $0.4750 to $0.5130 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.